» Articles » PMID: 27699443

A Systematic Review of Possible Serious Adverse Health Effects of Nicotine Replacement Therapy

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2016 Oct 5
PMID 27699443
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

We conducted a systematic literature review to identify and critically evaluate studies of serious adverse health effects (SAHEs) in humans using nicotine replacement therapy (NRT) products. Serious adverse health effects refer to adverse events, leading to substantial disruption of the ability to conduct normal life functions. Strength of evidence evaluations and conclusions were also determined for the identified SAHEs. We evaluated 34 epidemiological studies and clinical trials, relating NRT use to cancer, reproduction/development, CVD, stroke and/or other SAHEs in patients, and four meta-analyses on effects in healthy populations. The overall evidence suffers from many limitations, the most significant being the short-term exposure (≤12 weeks) and follow-up to NRT product use in most of the studies, the common failure to account for changes in smoking behaviour following NRT use, and the sparse information on SAHEs by type of NRT product used. The only SAHE from NRT exposure we identified was an increase in respiratory congenital abnormalities reported in one study. Limited evidence indicated a lack of effect between NRT exposure and SAHEs for CVD and various reproduction/developmental endpoints. For cancer, stroke and other SAHEs, the evidence was inadequate to demonstrate any association with NRT use. Our conclusions agree with recent statements from authoritative bodies.

Citing Articles

Ameliorative and protective effects of coenzyme Q10 against natural and chemical toxicity: a narrative review.

Keshavarzi M, Naraki K, Razavi B, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40080152 DOI: 10.1007/s00210-025-03992-5.


Long COVID - a critical disruption of cholinergic neurotransmission?.

Leitzke M, Roach D, Hesse S, Schonknecht P, Becker G, Rullmann M Bioelectron Med. 2025; 11(1):5.

PMID: 40011942 PMC: 11866872. DOI: 10.1186/s42234-025-00167-8.


Exploratory analysis on the association of dietary live microbe and non-dietary prebiotic/probiotic intake with serum cotinine levels in the general adult population.

Lin S, Zhu N, Zhu Y, Mao H, Zhang S Front Nutr. 2024; 11:1405539.

PMID: 38863585 PMC: 11165358. DOI: 10.3389/fnut.2024.1405539.


Concerns regarding the consequences of Nicotex for smoking and tobacco chewing cessation.

Garg R J Educ Health Promot. 2024; 13:159.

PMID: 38784268 PMC: 11114586. DOI: 10.4103/jehp.jehp_10_24.


Estimating the health impact of nicotine exposure by dissecting the effects of nicotine versus non-nicotine constituents of tobacco smoke: A multivariable Mendelian randomisation study.

Khouja J, Sanderson E, Wootton R, Taylor A, Church B, Richmond R PLoS Genet. 2024; 20(2):e1011157.

PMID: 38335242 PMC: 10883537. DOI: 10.1371/journal.pgen.1011157.


References
1.
Lee P . Epidemiological evidence relating snus to health--an updated review based on recent publications. Harm Reduct J. 2013; 10:36. PMC: 4029226. DOI: 10.1186/1477-7517-10-36. View

2.
Bradford S, Stamatovic S, Dondeti R, Keep R, Andjelkovic A . Nicotine aggravates the brain postischemic inflammatory response. Am J Physiol Heart Circ Physiol. 2011; 300(4):H1518-29. PMC: 3075028. DOI: 10.1152/ajpheart.00928.2010. View

3.
EPIFANO L, Di Vincenzo A, Fanelli C, Porcellati F, Perriello G, De Feo P . Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus. Eur J Clin Pharmacol. 1992; 43(3):257-63. DOI: 10.1007/BF02333019. View

4.
El-Mohandes A, Windsor R, Tan S, Perry D, Gantz M, Kiely M . A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers. Matern Child Health J. 2012; 17(5):897-906. PMC: 3679235. DOI: 10.1007/s10995-012-1069-9. View

5.
Tzivoni D, Keren A, Meyler S, Khoury Z, Lerer T, Brunel P . Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther. 1998; 12(3):239-44. DOI: 10.1023/a:1007757530765. View